Showing results (71-80 of 93) with videos related to
Sort By:
Pageof 10
International Journal of Urology : Official Journal of the Japanese Urological Association|March 8, 2021
Effect of optimal neoadjuvant chemotherapy on oncological outcomes of locally advanced bladder cancer with laparoscopic radical cystectomy: A matched-pair analysis in a multicenter cohortMasashi Kubota, Toru Kanno, Takahiro Inoue, et al.Cancer Medicine|April 8, 2020
Development and external validation of a preoperative nomogram for predicting pathological locally advanced disease of clinically localized upper urinary tract carcinomaTakashi Yoshida, Takashi Kobayashi, Takayuki Kawaura, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|April 22, 2020
Perioperative and oncological outcomes of laparoscopic radical cystectomy with intracorporeal versus extracorporeal ileal conduit: A matched-pair comparison in a multicenter cohort in JapanToru Kanno, Takahiro Inoue, Mutsushi Kawakita, et al.Nature Communications|February 17, 2026
Phenotype of circulating tumor-reactive T cells predicts immune checkpoint inhibitor response in non-small cell lung cancerKatsuhiro Ito, Kei Iida, Tomoko Hirano, et al.Urologic Oncology|May 13, 2022
Tolerability and treatment outcome of pembrolizumab in patients with advanced urothelial carcinoma and severe renal dysfunctionYuki Kita, Katsuhiro Ito, Sohei Kanda, et al.Iscience|October 13, 2025
Urothelial collective-gliding response acts as a toll-like receptor 4-associated defense mechanismNing Zhang, Takeshi Sano, Katsuhiro Ito, et al.Anticancer Research|November 1, 2023
Second-line Pembrolizumab for Metastatic Urothelial Carcinoma: Differences in Treatment Outcomes According to the Primary SiteNaotaka Nishiyama, Yuki Kita, Katsuhiro Ito, et al.Cancer Science|August 23, 2022
Immune-related adverse events in urothelial cancer patients: Adjustment for immortal time biasHikari Otsuka, Yuki Kita, Katsuhiro Ito, et al.Frontiers in Immunology|December 27, 2023
The combination of soluble forms of PD-1 and PD-L1 as a predictive marker of PD-1 blockade in patients with advanced cancers: a multicenter retrospective studyTakashi Kurosaki, Kenji Chamoto, Shinichiro Suzuki, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|February 2, 2024
Real-world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in JapanYuki Kita, Hikari Otsuka, Katsuhiro Ito, et al.Pageof 10